Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Market Cap: 1.833B for June 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 04, 2024 | 1.833B |
| June 03, 2024 | 1.833B |
| May 31, 2024 | 1.830B |
| May 30, 2024 | 1.826B |
| May 29, 2024 | 1.821B |
| May 28, 2024 | 1.825B |
| May 24, 2024 | 1.827B |
| May 23, 2024 | 1.829B |
| May 22, 2024 | 1.830B |
| May 21, 2024 | 1.828B |
| May 20, 2024 | 1.831B |
| May 17, 2024 | 1.830B |
| May 16, 2024 | 1.825B |
| May 15, 2024 | 1.832B |
| May 14, 2024 | 1.823B |
| May 13, 2024 | 1.823B |
| May 10, 2024 | 1.827B |
| May 09, 2024 | 1.819B |
| May 08, 2024 | 1.820B |
| May 07, 2024 | 1.820B |
| May 06, 2024 | 1.822B |
| May 03, 2024 | 1.825B |
| May 02, 2024 | 1.828B |
| May 01, 2024 | 1.822B |
| April 30, 2024 | 1.823B |
| Date | Value |
|---|---|
| April 29, 2024 | 1.820B |
| April 26, 2024 | 1.818B |
| April 25, 2024 | 1.816B |
| April 24, 2024 | 1.816B |
| April 23, 2024 | 1.818B |
| April 22, 2024 | 1.809B |
| April 19, 2024 | 1.804B |
| April 18, 2024 | 1.803B |
| April 17, 2024 | 1.803B |
| April 16, 2024 | 1.804B |
| April 15, 2024 | 1.806B |
| April 12, 2024 | 1.808B |
| April 11, 2024 | 1.813B |
| April 10, 2024 | 1.813B |
| April 09, 2024 | 1.814B |
| April 08, 2024 | 1.816B |
| April 05, 2024 | 1.809B |
| April 04, 2024 | 1.819B |
| April 03, 2024 | 1.811B |
| April 02, 2024 | 1.807B |
| April 01, 2024 | 1.803B |
| March 28, 2024 | 1.806B |
| March 27, 2024 | 1.804B |
| March 26, 2024 | 1.804B |
| March 25, 2024 | 1.794B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
86.78M
Minimum
Aug 11 2022
1.833B
Maximum
Jun 03 2024
424.75M
Average
329.32M
Median
Mar 23 2022
Market Cap Benchmarks
| AstraZeneca PLC | 241.52B |
| Landos Biopharma Inc (DELISTED) | 71.67M |
| Acasti Pharma Inc | 26.88M |
| Aurinia Pharmaceuticals Inc | 798.76M |
| Edesa Biotech Inc | 13.67M |
Market Cap Related Metrics
| PS Ratio | 713.16 |
| Price to Book Value | 7.580 |
| Price | 21.55 |
| Earnings Yield | -6.59% |